Breaking News, Financial News

Financial Report: Dendreon

Adds 42 new Provenge accounts

Dendreon

2Q Revenues: $73.3 million (-8%)

2Q Loss: $68.8 million (-28%)

YTD Revenues: $140.9 million (-13%)

YTD Loss: $140.8 million (-30%)

Comments: The company added 42 new accounts in the quarter for Provenge. Urology sales were up 37% in the quarter. Total operating expenses were $128.5 million in the quarter, down 21%.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters